Bacteremia caused by Mycobacterium wolinskyi.
Chen
Yu-Chuan
YC
Jou
Ruwen
R
Huang
Wei-Lun
WL
Huang
Shao-Tsung
ST
Liu
Keng-Chang
KC
Lay
Chorng-Jang
CJ
Chang
Shu-Mei
SM
Tseng
Chih-En
CE
Lai
Chun-Liang
CL
Su
Yu-Chieh
YC
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D016470:Bacteremia / Q000175:diagnosis* / Q000276:immunology / Q000382:microbiology; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007165:Immunosuppression Therapy / Q000009:adverse effects; D008228:Lymphoma, Non-Hodgkin / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D009165:Mycobacterium Infections, Nontuberculous / Q000175:diagnosis* / Q000209:etiology / Q000276:immunology; D020102:Mycobacterium smegmatis / Q000145:classification / Q000235:genetics / Q000302:isolation & purification*; D000069283:Rituximab; D055815:Young Adult
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab